Other
Cohort Study
0
Pipeline Programs↗
12
Active Trials↗
7
Companies Involved↗
Cohort Study is an early-stage landscape with 0 programs across 7 companies. The most active players are Pfizer, GSK, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
46
clinical trials
Completed17 · 37%
Unknown status15 · 33%
Recruiting6 · 13%
Not yet recruiting3 · 7%
Active, not recruiting2 · 4%
Withdrawn2 · 4%
Other1 · 2%
Clinical Trials
Trial Activity
46 trials
Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy
Recruiting·—·N/A·NCT05663580·1,500 enrolled
Cohort Study of Honghua Xiaoyao Tablets in the Treatment of Premenstrual Syndrome Based on Target Trial Emulation Framework
Not yet recruiting·—·N/A·NCT07171814·266 enrolled
DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
Not yet recruiting·—·N/A·NCT06884384·310 enrolled
Initiation of Exogenous Female Sex Hormones and Airway Responsiveness to Methacholine - A Prospective Cohort Study
Not yet recruiting·—·N/A·NCT06578169·300 enrolled
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)